Exhibitors

PL Poland
Stand No: 62C44
New
Biovico is rapidly growing mid-size biotech company, with a strong legacy in the development of innovative products with a particular focus on natural components and biotechnology. The company consequently realizes its aims including introduction and development of effective preparations in field of pharmaceuticals, medical devices and food supplements. From the year of establishment, the company has launched several medical devices and nutraceuticals in the area of orthopedics, rheumatology and neurology. Leader in the field of regenerative medicine (viscosupplementation, PRP therapy). Biovico has developed its own internal programs that generate novel technologies, medical devices based on our patented technology, therapeutics and nutraceuticals. These programs are at various stages of development (both marketed products as well as a research programs) and are available for partnering directly from Biovico. In addition, we offer a wide range of services dedicated to your specific needs such as the development and optimization of new research methods...
Location:
Sub-event: CPHI
GB United Kingdom
Stand No: 61D32
Established in 2011, CMAC is a world-class international centre for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future. The approaches developed and adopted within CMAC have been established through close collaboration with industry and the support of its partners, which include GlaxoSmithKline, AstraZeneca, Novartis, Bayer, Roche, Lilly and Takeda. The CMAC National Facility offers contract research support to industries through the delivery of services within crystallisation (batch & continuous), process development, formulation, product/process analysis and advanced materials characterisation. We are working with a range of companies based within the chemicals, agrichemicals and food industries applying our expertise in crystallisation, PAT and high end analytical services to these fields.
Location:
Sub-event: CPHI
DE Germany
Stand No: 41N42
New
CW Research & Management GmbH, certified according to EN ISO 9001:2015, is an independent Contract Research Organization operating in the pharmaceutical, biotechnology, medical device and healthcare industry. Our expertise combined with many years of experience is the basis of our corporate philosophy and our success. Our team has been successfully managing numerous projects since 1993 in Germany, Austria and Switzerland from our offices based in Munich, Vienna and Adlwang (Upper Austria). Together with our contactors we manage your projects all across over Europe. Each project is different - unique in its structure, objectives and requirements. This requires the development of individually adapted solutions - individuality rather than uniformity. The diversity of our service portfolio allows us to develop tailor-made solutions for your company (all-inclusive concept as well as individual services). Our committed team of experts provides you with services on the following areas: Clinical Trials - Planning/Monitoring/Evaluation, Medical Writing, Data...
Location:
DE Germany
Stand No: 60F72
The focus of Enzymicals is to provide integrated solutions for biocatalytic applications. Dedicated to design, develop and implement cost-effective, sustainable and scalable chemo-biocatalytic routes to APIs and intermediates, Enzymicals offers recognized expertise in the use of enzymatic processes for complex chemicals synthesis. The independent enterprise provides state of the art SOLUTIONS in development, optimization and piloting of robust chemo-enzymatic processes for the production of fine & specialty chemicals. The company manufactures a range of CHEMICALS as chiral building blocks, intermediates and specialty chemicals as well offer custom synthesis on request. Enzymicals offers a broad selection of recombinant ENZYMES suitable for research, development, production and diagnostics as well as a tailor-made protein expression and optimization service. Enzymicals service covers the whole value chain towards a tailor-made process for a special application: enzyme identification, expression, characterization, improvement and application in an efficient production process. Together with our network partners, we expand our...
Location:
Sub-event: CPHI
DE Germany
Stand No: 41A20
New
Gen-Plus is a privately-owned company located in Munich. We develop formulation and technology concepts for pharmaceutical industries (NCE, value-added-Generics, OTC). This includes solid/semisolids, patches and thin films from early idea to IMP production under GMP. Further in-house capabilities: narcotics&high potent handling (isolators), high-tech analytics incl. skin permeation testing, 2D/3D-API-printing.
Location:
Sub-event: ICSE
Zone: NEP ICSE
IN India
Stand No: 80F52
Hikal is a reliable long-term outsourcing partner and supplier of key active ingredients and intermediates to companies in the Pharmaceuticals, Crop Protection and Specialty Chemicals industry. Our advanced manufacturing facilities have been certified by the US FDA, MHRA, EDQM, COFEPRIS,TGA, and are ISO 9001:2008, ISO 14001 and OHSAS 18001 certified. Strengths: Supply and Regulatory support on Generic APIs, Custom Synthesis; Contract manufacturing; Process development and Scale-up expertise; Respect for Intellectual Property. Hikal has five state-of-the-art manufacturing facilities in India at Maharashtra (Taloja and Mahad), Gujarat (Panoli) and Bangalore (Jigani) including an R&D centre and a state-of-the art R&D centre at Pune
Location:
Sub-event: CPHI
Zone: API
IT Italy
Stand No: 41K43
Labomar is a research, development and manufacturing company devoted to innovation in food supplements, medical devices, foods for special medical purposes and cosmetics; it offers a full service throughout the different development phases. Labomar R&D Department designs innovative patents that ensure more effective delivery systems. Labomar has also a licensing product line Certifications and Compliances ISO 9001:2008 ISO 13485:2012 GMP Nutritional Supplements .
Location:
DE Germany
Stand No: 41A03
New
MJR PharmJet is a provider of formulation development and manufacturing services for pharmaceuticals with a special focus on the low soluble substances. We offer a broad range of particle types and technologies in order to meet your needs in enhanced bioavailability or stability, preventing fed/fasted state differences, taste and smell masking, ER or MR formulations. Services all around the particles: Development of nanoparticle systems for oral, parenteral, pulmonary or topical applications together with our partner leon-nanodrugs Development of encapsulation system for taste/smell masking Enhanced stability in liquid for RTU formulations Micro-particulate systems for extended release formulations Particle based drug delivery systems and drug targeting Particle technologies screening studies for NCEs together with our partner leon-nanodrugs Particles for in-vivo and in-vitro diagnostics Particle systems for medicinal product applications Furthermore, we provide technology transfer services for your established nanoparticle and microparticle formulations to increase the GMP compliance and efficiency of the production...
Location:
Sub-event: ICSE
Zone: NEP ICSE
AT Austria
Stand No: 41G30
NP&D is a developer, producer and distributor of nutritional / food supplements for joints, back, spinal discs, prostrate, osteoporosis, etc. Our brand portfolio includes Arthrobene, vertebene, Biobene and Primabene. We are also supplier and distributor of raw ingredients with its focus on plant/vegetable oils and fats for cosmetics and nutrition. We are looking for distributors of our nutritional supplement lines.
Location:
IN India
Stand No: 41N44
New
Raptim Research Ltd. is a quality-oriented full-service contract (clinical) research organization. Raptim provides end-to-end services to global Pharmaceutical (generic as well as research-based), Biotechnology and Cosmetic industry. The studies done at Raptim are globally submitted and approved by various regulatory agencies including USFDA, EMA, UK MHRA, Canada (TPD), WHO and etc. Raptim Research Ltd., incorporated in the year 2005, has its facilities based in Navi Mumbai and Business Office in Navi Mumbai as well as New Jersey, USA. Raptim is leader following activities: Bioequivalence / Bioavailability Studies (BE/BA studies) PK end-point studies PD end-point studies Clinical trials – phase II & IV Studies on Special Population Apart from the above, Raptim has developed expertise in niche area of drug development and has pioneered in testing/screening Dermal Topical Products including Cosmetic Products as well as inhalation products. These include: In vitro Release/Permeation (IVRT/IVPT) studies In vivo – Tape Stripping studies In...
Location:
IN India
Stand No: 40F43
Syngene International Limited, (BSE code: 539268, NSE Id: SYNGENE, ISIN Id: INE398R01022) is India's largest Contract Research Organization offering a suite of integrated, end-to-end discovery, development and manufacturing services for novel molecular entities across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. Our service offerings in discovery and development cover multiple domains across small molecules, large molecules, antibody-drug conjugates (“ADC”) and oligonucleotides. Our integrated discovery and development platforms help organizations conduct discovery (from hit to candidate selection), development (including pre-clinical and clinical studies, analytical and bio-analytical evaluation, formulation development and stability studies) and pilot manufacturing (scale-up, pre-clinical and clinical supplies) with a distinctive economic advantage. We are also in the process of setting up a large scale manufacturing facility at Mangalore to strengthen our commercial manufacturing services. Syngene brings together a state-of-the-art infrastructure spread across 1.3 Mn sq. ft. and a highly experienced team...
Location:
DE Germany
Stand No: 110G11
WeylChem InnoTec GmbH is a new and innovative Service Company within the WeylChem Group of Companies. It represents the technology and innovation backbone of the WeylChem Group of Companies. We serve customers in the fine chemical and pharmaceutical industry with our competencies in Analytics, Contract Research and Piloting as well as Specialized Custom Synthesis and Process development. And this not only since our foundation in 2017: we look back on a long track record of successful projects since WeylChem InnoTec has got his roots in Höchst AG, Allessa GmbH and Allessa Syntec. From the very first idea and concept to production, more than 120 highly skilled scientists and technicians, embedded in a unique flexible environment and connected to an excellent infrastructure, are dedicated to turn your ideas into reality.
Location: